par Metzger-Filho, Otto;Moulin, Camilo;D'Hondt, Veronique
Référence Current opinion in oncology, 22, 5, page (513-520)
Publication Publié, 2010-09
Référence Current opinion in oncology, 22, 5, page (513-520)
Publication Publié, 2010-09
Article révisé par les pairs
Résumé : | Epithelial ovarian cancer (EOC) is a prevalent gynecologic malignancy whose prognosis in most cases remains poor despite advances in therapy. In this article, we critically review the available clinical evidence for the choice of first-line chemotherapy in EOC and discuss promising therapeutic strategies. |